Point72 Middle East FZE’s Guardant Health GH Stock Holding History

Point72 Middle East FZE’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-47,360	Closed	-$1.28M	–	537
2023 Q4	$1.28M	Buy	+47,360	New	+$1.24M	0.04%	521
2023 Q2	–	Sell	-31,441	Closed	-$737K	–	1735
2023 Q1	$737K	Buy	31,441 +21,441	+214%	+$612K	0.03%	595
2022 Q4	$272K	Buy	+10,000	New	+$458K	0.01%	929

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Middle East FZE's GH Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Guardant Health (GH) in Q1 2024, closing a stake of 47,360 shares — an estimated $1.28M sold.

Point72 Middle East FZE first reported a position in GH in Q4 2022 and held it in 3 quarters. The position peaked at $1.28M in Q4 2023. 257 funds tracked by Wall St. Rank hold GH as of Q1 2024.

Point72 Middle East FZE reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
Point72 Middle East FZE sold 47,360 Guardant Health shares in Q1 2024, an estimated $1.28M.
Point72 Middle East FZE first reported a position in Guardant Health in Q4 2022 and held it in 3 quarters.
Point72 Middle East FZE's Guardant Health position peaked at $1.28M in Q4 2023.
257 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.